Focus Stocks
Trading Idea - Is Teva close to Resistance?
Published on Monday, 23 August 2010 07:12 Written by TradersHuddle Staff
New York, August 23rd (TradersHuddle.com) - Shares of Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) are trading very close to calculated resistance at $50.78 with the current price action closing at just $50.28 placing the stock near levels that make it difficult to buy.
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis.
Teva's current stock range is defined by current calculated support defined at $46.99 and by the resistance level at $50.78, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Teva, as the stock is well above support, however, as the stock pulls back towards $46.99 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $50.78 then traders will get an opportunity to enter Teva stock by establishing a position as the stock moves to a higher range.
Related Articles
- Neutral Short Term Pattern on Teva
- ChromaDex Corp. Names Consumer Products Veteran Jeffrey Himmel CEO
- Teva to Report Fourth Quarter and Full Year 2011 Financial Results on February 15, 2012
- Teva to Present at the 30th Annual J.P. Morgan Healthcare Conference
- Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with COPAXONE®
- Teva Announces Management Succession
- Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe
- Teva Lower With High Volume
- Teva Provides 2012 Non-GAAP Financial Outlook; 2012 Non-GAAP Diluted EPS of $5.48 to $5.68
- Teva Announces $3 billion Share Repurchase Program
Related Partner Headlines
- UPDATE: Morgan Stanley Downgrades Teva Pharmaceuticals to Equal-Weight - Benzinga
- Morgan Stanley Downgrades Teva Pharmaceutical to Equal-weight - Benzinga
- Teva Gets Upgrade on Revenue Growth - TheStreet.com
- Teva Pharmaceutical Industries Ltd Stock Upgraded (TEVA) - TheStreet.com
- Teva Taps Bristol-Myers' Levin as Next CEO - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Winner - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Health Care Winner - TheStreet.com
- Teva Stock To Go Ex-dividend Tomorrow (TEVA) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Feltl and Company Maintains SPS Commerce at Strong Buy, Raises PT from to - Benzinga -
Apple TV to Cost ,000? - Benzinga -
Cosi Initiates Consulting Agreement With Brad Blum - Benzinga -
KEMET Says Not Impacted By Closing of Global Advanced Metals' Tantalum Mine - Benzinga -
Ford Names Jon Huntsman to Board of Directors - Benzinga -
UPDATE: Ford CFO Lewis Booth and Global Product Chief Derrick Kuzak to Retire; Veteran Executives Named as Successors - Benzinga -
Array BioPharma Announces Proposed Public Offering of 20M Shares - Benzinga -
Despite What Clint Says, It's Not Halftime for Detroit Housing - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:0.00 (0.00%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:0.00 (0.00%)In The Wires
-
WisdomTree Dividend ex-Financials Fund (DTN) Surpasses $1 Billion in Assets -
Baldwin Announces Results for Second Quarter FY2012 -
Lisa Featherngill to Head Planning for Wells Fargo’s Abbot Downing -
CPI Corp. Joins OTCQX -
Summit Hotel Properties, Inc. Announces Birmingham Hilton Garden Inn -
J.P. Morgan Launches Intuitive, Customizable Portal for Fund Administration Clients -
American Heart Association's School Challenge Seeks Next Generation of Lifesavers -
Wind River Announces Commitment to Future Airborne Capability Environment (FACE) Consortium










